Xiaoqing Li

8.0k citations
271 papers · 5.9k indexed · 1 hit paper · h-index 42
Topics
MicroRNA in disease regulation (23 papers)Cancer-related molecular mechanisms research (19 papers)Cancer Cells and Metastasis (14 papers)
Partner nations
ChinaUnited StatesRussia

In The Last Decade

Xiaoqing Li

254 papers receiving 5.8k citations

Hit Papers

Cancer-associated fibroblasts induce epithelial–mesenchym...20132026201720212013100200300400500

Peers

Xiaoqing Li
Comparison fields: 5 of 153
  • Molecular Biology 3.1k
  • Oncology 1.3k
  • Cancer Research 1.2k
  • Immunology 870
  • Pulmonary and Respiratory Medicine 514
Replace Wei Zhang with:
Wei Zhang China
Christopher Gerner Austria
Li Sun China
Jin Jin China
Yong Xia China
Fang Li China
Yang Li China
Jeffrey G. McDonald United States
Jing Li China
Zhihua Chen China
Xiaoqing Li relative to Wei Zhang China Wei Zhang's profile →
Citations per field
00.5×1.7×
Wei Zhang · 1×
Citations per year

Countries citing papers authored by Xiaoqing Li

Since Specialization
Citations

This map shows the geographic impact of Xiaoqing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoqing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoqing Li more than expected).

Fields of papers citing papers by Xiaoqing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoqing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoqing Li. The network helps show where Xiaoqing Li may publish in the future.

Co-authorship network of co-authors of Xiaoqing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoqing Li. A scholar is included among the top collaborators of Xiaoqing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoqing Li. Xiaoqing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 1
5 3
6 1
7 2
8 2
9 3
10 3
11 1
12 1
13 1
14 44
15 1
16 17
17 0
18 26
19 24
20 78

About Xiaoqing Li

Xiaoqing Li is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 271 papers that have together received 5.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (19 papers) and Cancer Cells and Metastasis (14 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.3k citations) and Molecular Biology (3.1k citations). Xiaoqing Li has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Yu-Mei Feng, Yingying Yu, Qing-Shan Wang, Andrei L. Osterman, Dmitry A. Rodionov, Xian‐Ming Chen, Margaret F. Romine, Youwen You, Minghui Yang and Fuyu Guan. Their work appears in journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026